Clinical Trial Update: Study of Parkinson's Early Stage With Deferiprone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of deferiprone in early-stage Parkinson's disease has completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-04-10